During the past decade, Ospedale Di Sassuolo Spa - Ematologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Di Sassuolo Spa - Ematologia" are "Acute Myeloid Leukemia" (1 trials), "Chronyc Myeloid Leukemia" (1 trials) and "Hematologic Malignancies" (1 trials). Many other conditions were trialed in "Ospedale Di Sassuolo Spa - Ematologia" in a lesser frequency.

Most popular intervention types in "Ospedale Di Sassuolo Spa - Ematologia" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Imatinib" (1 trials), "Nilotinib" (1 trials), "Quality of life assessment" (1 trials) and "Venetoclax plus HMA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Di Sassuolo Spa - Ematologia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Di Sassuolo Spa - Ematologia". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ospedale Di Sassuolo Spa - Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Di Sassuolo Spa - Ematologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".